维普中文期刊产品整合服务
26篇 您的检索式:作者名="RIPOLL N"
    题名 作者 年代 出处 被引量
1Oral probiotic VSL #3 attenuates the circulatory disturbances of patients with cirrhosis and ascites显示文摘Diego Rincón Javier Vaquero Ana Hernando Evelyn Galindo Cristina Ripoll Marta Puerto Magdalena Salcedo Rubén Francés Ana Matilla María V. Catalina Gerardo Clemente José Such Rafael Ba?ares 2014Liver Int2014,,10:2
2Expression of members of Wnt and Frizzled genefamilies in the postnatal rat cochlea 显示文摘Daudet N Ripoll C Moles JP 2002Brain Res Mol Brain Res2002,105,:1
3Anesthetic management in a patient with bullous emphysema显示文摘Ruiz Carbonell JR Soliveres Ripoll J Solaz Rold a n C 2008Rev Esp Anestesiol Reanim2008,55,4:1
4Characterizatiaon of atypical cells in the juvenile rat organ of corti after aminoglycoside ototoxicity显示文摘Daudet N Vago P Ripoll C 1998Comp Neurol1998,401,:1
5Transforming growth factor-alpha-induced cellular changes in orgaotypic cultures of juvenile,amikacin-treated rat organ of corti显示文摘Daudet N Ripoll C Lenoir M 2002J Comp Neurol2002,442,:1
6Restoring silvopastures with oak saplings : effects of mulch and diameter class on survival, growth, and annual leaf-nutrient patterns 显示文摘JIMENEZ M N PINTO J R RIPOLL M A 2014Agroforestry Systems2014,88,5:1
7Time- to- Contact Estimation of Accelerated Stimuli Is Based on First - Order Information 显示文摘Benguigui N Ripoll H Broderick M P 2003Journal of Experimental Psychology :Human Perception and Performance2003,29,6:1
8Transforming growth factor- alpha-induced cellular changes in organotypie cultures of juvenile, amikacin-treated rat organ of corti显示文摘Daudet N Ripoll C Lenoir M 2002J Comp Neurol2002,442,1:1
9Characterization of atypical cells in the juvenile rat organ of Corti after aminoglycoside ototoxicity显示文摘Daudet N Vagop Ripoll C 1998J Cmo p Neurol1998,401,:1
10Transforming growth factor-alpha-induced cellular changes in organotypic cultures of juvenile,amikacin-treated rat organ of corti显示文摘Daudet N Ripoll C Lenoir M 2002J Comp Neurol2002,442,1:1
11Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test显示文摘Ripoll N Florence C 2005Psychopharmacology2005,179,2:1
12Implication of 5-HT(2) receptor subtypes in the mechanism of action of antidepressants in the four plates test显示文摘NIC DHONNCHADHA BA RIPOLL N CLENET F 2005Psychopharmacology (Berl)2005,179,2:1
13Inhibition of lipidmetabolic enzymes using Mangifera indica extracts显示文摘Moreno D Ripoll C Ilic N 0,,01:1
14Nicotinic receptors and Alzheimer's disease 显示文摘Boufin M Ripoll N Dailly E 2003Curt Med Res Opin2003,19,:1
15Cardiac Dysfunction During Liver Transplantation: Incidence and Preoperative Predictors显示文摘Cristina Ripoll María-Vega Catalina Raquel Yotti Luis Olmedilla José Pérez-Pe?a Oreste Lo Iacono Diego Rincón Miguel Angel García-Fernández Javier Bermejo Rafael Ba?ares 2008Transplantation2008,,12:1
16Effectiveness of contrast-enhanced uhrasound for characterisation of intestinal inflammation in Crohn's disease: a comparison with surgical histopa/hology analysis显示文摘RIPOLLES T RAUSELL N PAREDES J M 2012Journal of Crohn''s Colitis2012,6,3:1
17Everolimus immunosuppression reduces the serum expression of fibrosis markers in liver transplant recipients显示文摘AIM: To evaluate the expression of serum fibrosis markers in liver transplantation(LT) recipients on everolimus monotherapy compared to patients on an anti-calcineurin regimen.METHODS: This cross-sectional case-control study included LT patients on everolimus monotherapy(cases)(E)(n = 30) and matched controls on an anticalcineurin regimen(calcineurin inhibitors, CNI), paired by etiology of liver disease and time since LT(n = 30). Clinical characteristics, blood tests and elastography were collected. Serum levels of transforming growth factor-β(TGF-β), angiopoietin-1, tumor necrosis factor(TNF), platelet derived growth factor, amino-terminal propeptide of type Ⅲ procollagen(PⅢNP), hyaluronicacid(HA), VCM-1(ng/m L), interleukin(IL)-10, interferoninducible protein 10(IP-10), vascular endothelial growth factor and hepatocyte growth factor(HGF)(pg/m L) were determined by enzyme-linked immunosorbent assay. Expression of these markers between E and CNI was compared. Stratified analysis was done according to factors that may influence liver fibrosis. Variables are described with medians(interquartillic range) or percentages.RESULTS: A total of 60 patients [age: 59(49-64), hepatitis C virus(HCV): n = 21(35%), time from LT: 73 mo(16-105)] were included. Patients had been on everolimus for a median of 15 mo. No differences in inflammatory activity, APRI test or liver elastography were found between the groups. No significant differences were observed between the groups in serum levels of PⅢ NP, metalloproteinase type = 1, angiopoietin, HGF, IP-10, TNF-α, IL-10 and vascular cell adhesion molecule. Patients on E had a lower expression of TGF-β [E: 12.7(3.7-133.6), CNI: 152.5(14.4-333.2), P = 0.009] and HA [E: 702.89(329.4-838.2), CNI: 1513.6(691.9-1951.4), P = 0.001] than those on CNI. This difference was maintained in the stratified analysis when recipient age is more than 50 years(TFG-β1: P = 0.06; HA: P = 0.005), in patients without active neoplasia(TFG-β1, P = 0.009; HA: P = 0.01), according to time since LT(> than 5 years, TFG-β1: P = 0.001; HA: P = 0.002), related to previous history of biliary complications(HA: P = 0.01) and HCV recurrence(HA: P = 0.004). Liver transplant recipients with everolimus monotherapy had less serum expression of TGF-β y HA than matched patients with anti-calcineurins. This difference remains when classifying patients according to donor age and time since LT. Due to the small sample size, when examining patients with a prior history of biliary complications or recurrent HCV, the difference was nonsignificant but trends towards the lower expression of TFG-β1 in the everolimus group. Mammalian target of rapamycin(m TOR) plays a role in the transformation of quiescent hepatocellular stellate cell to their activeprofibrotic state, and experimental models have demonstrated the potential activity of m TOR inhibition in attenuating fibrogenesis.CONCLUSION: This study supports a possible role of everolimus in liver fibrosis modulation after LT in a clinical setting and suggests that tailoring immunosuppression could avoid fibrosis progression in the allograft.Ainhoa Fernández-Yunquera Cristina Ripoll Rafael Banares Marta Puerto Diego Rincón Ismael Yepes Vega Catalina Magdalena Salcedo 2014World Journal of Transplantation2014,4,2:1
18Contrast-enhanced ultrasonography: Usefulness in the assessment of postoperative recurrence of Crohn’s disease显示文摘José María Paredes Tomás Ripollés Xavier Cortés Nadia Moreno María Jesús Martínez Marco Bustamante-Balén Fructuoso Delgado Eduardo Moreno-Osset 2012Journal of Crohn’s and Colitis2012,,:1
19The current challenges of the treatment of depression:venlafaxina extended release and remission outcomes in real-world clinical practice显示文摘Ros Montalbán S Mora Ripoll R Garcia-Garcia M 2005Actas Esp Psiquiatr2005,33,3:1
20Antidepressant-like effects in various mice strains in the tail suspension test显示文摘Ripoll N David DJ Dailly E Hascot M Bourin M 0,,02:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费